M. van den Boom, K. Bennani, G. B. Migliori, L. D'Ambrosio, R. Centis, A. Parvez Sayed, H.Y. Atta, Y. Hutin
{"title":"承诺、伙伴关系和业务研究:11 个欧洲监测报告国家实现消除结核病的三个优先事项","authors":"M. van den Boom, K. Bennani, G. B. Migliori, L. D'Ambrosio, R. Centis, A. Parvez Sayed, H.Y. Atta, Y. Hutin","doi":"10.5588/ijtldopen.23.0470","DOIUrl":null,"url":null,"abstract":"BACKGROUND: In 2022, 11 of 22 Member States of the WHO Eastern Mediterranean Region (EMR) had an estimated TB incidence of <20 cases per 100,000 population. We assessed preparedness for elimination and provided recommendations to pursue the process.METHODS: We surveyed 11 EMR\n national TB programme managers and collected information on eight TB elimination framework domains using a close-ended data collection tool. We compiled, consolidated and validated data, including a virtual consultation before triangulating data with other sources.RESULTS: Implementation\n was sufficient (≥74%) for 5 of 8 domains, highest for TB infection management, TB preventive treatment, laboratory service, drug management, drug-resistant TB and TB-HIV collaboration (89%, 83% and 78%, respectively). Countries ranked lowest for commitment (73%),\n operational research and infection control (63%), and partnership/collaborations (41%). Five countries reached >80% when consolidating the responses, reaching sufficient from all domains. Two reached <50%.CONCLUSION: Key identified obstacles to TB elimination\n in EMR were insufficient commitment/financing, suboptimal partnerships/collaborations and operational research calling for 1) all-stakeholder-inclusive, sustainably funded TB elimination plans, 2) cost-effective tools to exchange strategic information and build operational research capacity,\n and 3) improved collaboration.","PeriodicalId":516613,"journal":{"name":"IJTLD OPEN","volume":"48 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB elimination\",\"authors\":\"M. van den Boom, K. Bennani, G. B. Migliori, L. D'Ambrosio, R. Centis, A. Parvez Sayed, H.Y. Atta, Y. Hutin\",\"doi\":\"10.5588/ijtldopen.23.0470\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND: In 2022, 11 of 22 Member States of the WHO Eastern Mediterranean Region (EMR) had an estimated TB incidence of <20 cases per 100,000 population. We assessed preparedness for elimination and provided recommendations to pursue the process.METHODS: We surveyed 11 EMR\\n national TB programme managers and collected information on eight TB elimination framework domains using a close-ended data collection tool. We compiled, consolidated and validated data, including a virtual consultation before triangulating data with other sources.RESULTS: Implementation\\n was sufficient (≥74%) for 5 of 8 domains, highest for TB infection management, TB preventive treatment, laboratory service, drug management, drug-resistant TB and TB-HIV collaboration (89%, 83% and 78%, respectively). Countries ranked lowest for commitment (73%),\\n operational research and infection control (63%), and partnership/collaborations (41%). Five countries reached >80% when consolidating the responses, reaching sufficient from all domains. Two reached <50%.CONCLUSION: Key identified obstacles to TB elimination\\n in EMR were insufficient commitment/financing, suboptimal partnerships/collaborations and operational research calling for 1) all-stakeholder-inclusive, sustainably funded TB elimination plans, 2) cost-effective tools to exchange strategic information and build operational research capacity,\\n and 3) improved collaboration.\",\"PeriodicalId\":516613,\"journal\":{\"name\":\"IJTLD OPEN\",\"volume\":\"48 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IJTLD OPEN\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5588/ijtldopen.23.0470\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJTLD OPEN","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5588/ijtldopen.23.0470","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB elimination
BACKGROUND: In 2022, 11 of 22 Member States of the WHO Eastern Mediterranean Region (EMR) had an estimated TB incidence of <20 cases per 100,000 population. We assessed preparedness for elimination and provided recommendations to pursue the process.METHODS: We surveyed 11 EMR
national TB programme managers and collected information on eight TB elimination framework domains using a close-ended data collection tool. We compiled, consolidated and validated data, including a virtual consultation before triangulating data with other sources.RESULTS: Implementation
was sufficient (≥74%) for 5 of 8 domains, highest for TB infection management, TB preventive treatment, laboratory service, drug management, drug-resistant TB and TB-HIV collaboration (89%, 83% and 78%, respectively). Countries ranked lowest for commitment (73%),
operational research and infection control (63%), and partnership/collaborations (41%). Five countries reached >80% when consolidating the responses, reaching sufficient from all domains. Two reached <50%.CONCLUSION: Key identified obstacles to TB elimination
in EMR were insufficient commitment/financing, suboptimal partnerships/collaborations and operational research calling for 1) all-stakeholder-inclusive, sustainably funded TB elimination plans, 2) cost-effective tools to exchange strategic information and build operational research capacity,
and 3) improved collaboration.